Cleveland
BioLabs, Inc.
|
||
(Name
of Issuer)
|
||
Common
Stock
|
||
(Title
of Class of Securities)
|
||
185860-10-3
|
||
(CUSIP
Number)
|
||
December
31, 2010
|
||
(Date
of Event Which Requires Filing of this Statement)
|
¨
|
Rule
13d-1(b)
|
|
¨
|
Rule
13d-1(c)
|
|
x
|
Rule
13d-1(d)
|
CUSIP
NO.
185860-10-3
|
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Michael
Fonstein
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||
3
|
SEC
USE ONLY
|
|||
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Russian
Federation
|
|||
NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING POWER
1,545,950
|
||
6
|
SHARED
VOTING POWER
|
|||
7
|
SOLE
DISPOSITIVE POWER
1,
545,950
|
|||
8
|
SHARED
DISPOSITIVE POWER
|
|||
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,
545,950
|
|||
10
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|||
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.3%
|
|||
12
|
TYPE
OF REPORTING PERSON
IN
|
Item
5.
|
Ownership of Five
Percent or Less of a Class
|
Item
6.
|
Ownership of More than
Five Percent on Behalf of Another
Person
|
Item
7.
|
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported on by
the Parent Holding Company or Control
Person
|
Item
8.
|
Identification and
Classification of Members of the
Group
|
Item
9.
|
Notice of Dissolution
of Group
|
Certification
|
Date:
February 4, 2011
|
MICHAEL
FONSTEIN
|
|
/s/
Michael Fonstein
|
||
Name:
Michael Fonstein
Title:
President and Chief Executive
Officer
|